high response
Recently Published Documents


TOTAL DOCUMENTS

663
(FIVE YEARS 154)

H-INDEX

41
(FIVE YEARS 11)

2022 ◽  
Author(s):  
Shiqiang Zhou ◽  
Huapeng Wang ◽  
Jicu Hu ◽  
Tianping Lv ◽  
Qian Rong ◽  
...  

Formaldehyde is a common carcinogen in daily life and harmful to health. The detection of formaldehyde by a metal oxide semiconductor gas sensor is an important research direction. In this...


Blood ◽  
2021 ◽  
Vol 138 (Supplement 1) ◽  
pp. 4147-4147
Author(s):  
Satoshi Funakoshi

Abstract Human blood group antigens are glycoproteins and glycolipids expressed on the surface of red blood cells and a variety of human tissues. This study aimed to determine if there is an association between ABO blood type and the efficacy of HIF-PH inhibitors. Roxadustat and daprodustat are potent inhibitors of HIF-PH and capable of stimulating erythropoiesis in patients on patients with impaired renal function. These two compounds are reported to act mechanistically similar but display differences in their effects on cells, and the differences may affect their efficacy in the treatment of renal anemia in HD patients. In this study we compared the response rate by blood type between roxadustat and daprodustat, respectively. Sixty-eight HD patients treated with roxadustat (20-100mg, 3/week) and ninety-five treated with daprodustat (1-12mg, daily) were recruited in our observational study. We defined >1.5g/dL increase in hemoglobin as effective, and <1.5g/dL decrease as ineffective. As shown in the figure, type A had a significantly high response rate at 47% in HD patients treated with roxadustat. On the other hand, type O had a significantly high response rate at 55% in those who were treated with daprodustat. We found the association in the effectiveness of roxadustat on the treatment for anemia in HD patients in type A, while the effectiveness was higher in type O treated with daprodustat. The results suggest that the therapeutic effect of HIF-PH inhibitors may differ depending on the blood type. Figure 1 Figure 1. Disclosures No relevant conflicts of interest to declare.


2021 ◽  
Vol 23 (Supplement_6) ◽  
pp. vi84-vi84
Author(s):  
Nobuyoshi Sasaki ◽  
Keiichi Kobayashi ◽  
Kuniaki Saito ◽  
Ryo Onoda ◽  
Yousuke Seiya ◽  
...  

Abstract BACKGROUNDS Prognosis of relapsed primary central nervous system lymphoma (rPCNSL) is poor ranging between 2.2 and 16 months, and the optimal treatment strategy has not been established. Tirabrutinib is a second generation Bruton’s tyrosine kinase (BTK) inhibitor, approved by the Japanese Pharmaceutical and Medical Devices Agency (PMDA) for relapsed and refractory (r/r) PCNSL in March 2020. While an overall response rate (ORR) of 64% and progression-free survival (PFS) of 2.9 months was reported in a phase 1/2 study, the real-world treatment results of rPCNSL treated with tirabrutinib have not been investigated yet. METHODS Treatment results of rPCNSL patients treated with tirabrutinib at the author’s institution including response rate, PFS, overall survival (OS), and toxicity profiles were retrospectively analyzed. RESULTS Eleven patients were identified (median age: 73 [range: 50-83], median PFS: 70 [range: 40-90]). Response was CR in four (36.4%), PR in five (45.4%), PD in two (18.2%) patients, providing with an ORR of 81.8%. At a median follow up of 25.7 months, relapse was observed in seven patients (63.6%), and median PFS was 3.0 months. Durable remission of more than six months was obtained in four patients (36.4%). As for toxicities, six patients (54.5%) had skin-related disorders, which lead to tirabrutinib interruption in two (18.2%), dose reduction in three (27.3%), and discontinuation in two patients (18.2%). Grade 3/4 hematological toxicities were grade 4 neutropenia in one, and grade 3 lymphopenia in five patients (45.4%). No deaths have been observed. DISCUSSION Tirabrutinib monotherapy achieved a high response rate in rPCNSL, while skin-related disorders appeared to be the major obstacle leading to treatment interruption or discontinuation. Overall median PFS was in line with the phase 1/2 study. A subset of patients achieved durable remission, suggesting its strong benefit in certain patients. Further investigation of predictive biomarkers for response to tirabrutinib is warranted.


2021 ◽  
Vol 16 (2) ◽  
Author(s):  
Soheil Hashtarkhani ◽  
Behzad Kiani ◽  
Alireza Mohammadi ◽  
Shahab MohammadEbrahimi ◽  
Mohammad Dehghan-Tezerjani ◽  
...  

Pre-hospital care is provided by emergency medical services (EMS) staff, the initial health care providers at the scene of disaster. This study aimed to describe the characteristics of EMS callers and space-time distribution of emergency requests in a large urban area. Descriptive thematic maps of EMS requests were created using an empirical Bayesian smoothing approach. Spatial, temporal and spatio-temporal clustering techniques were applied to EMS data based on Kulldorff scan statistics technique. Almost 225,000 calls were registered in the EMS dispatch centre during the study period. Approximately two-thirds of these calls were associated with an altered level of patient consciousness, and the median response time for rural and urban EMS dispatches was 12.2 and 10.1 minutes, respectively. Spatio-temporal clusters of EMS requests were mostly located in central parts of the city, particularly near the downtown area. However, high-response time clustered areas had a low overlap with these general, spatial clusters. This low convergence shows that some unknown factors, other than EMS requests, influence the high-response times. The findings of this study can help policymakers to better allocate EMS resources and implement tailored interventions to enhance EMS system in urban areas.


2021 ◽  
pp. 2108891
Author(s):  
Hyeuk Jin Han ◽  
Gyu Rac Lee ◽  
Yujin Han ◽  
Hanhwi Jang ◽  
Eugene N. Cho ◽  
...  

2021 ◽  
Vol 21 ◽  
pp. S154
Author(s):  
Ioannis Ntanasis-Stathopoulos ◽  
Maria Gavriatopoulou ◽  
Panagiotis Malandrakis ◽  
Despina Fotiou ◽  
Magdalini Migkou ◽  
...  

2021 ◽  
Vol 17 (4) ◽  
pp. 109-121
Author(s):  
K. Manikandan ◽  
Niveditha V. R. ◽  
Sudha K. ◽  
Magesh S. ◽  
Radha Rammohan S.

RFM (recency, frequency, monetary) examination is a method to perceive high-response customers in promoting progressions and to improve general response rates, which is remarkable and is comprehensively associated today. Less extensively understood is the estimation of applying RFM scoring to a customer database and evaluating customer advantage. A customer who has passed by an e-keeping cash site recently (R) and frequently (F) and influenced a huge amount of monetary to esteem (M) through portion and standing solicitations is presumably going to visit and make portions yet again. After appraisal of the customer's lead using specific RFM criteria, the RFM score is related to the bank excitement, with a high RFM score being more important to the bank by and by and later on.


Sign in / Sign up

Export Citation Format

Share Document